Expression of the blood-group-related antigens Sialyl Lewis a, Sialyl Lewis x and Lewis y in term placentas of normal, preeclampsia, IUGR- and HELLP-complicated pregnancies

Histochemistry and Cell Biology

Volumn 128, Issue 1, 2007, Pages 55-63

  Minas, Vassilis ^a   Mylonas, Ioannis ^b   Schiessl, Barbara ^b   Mayr, Doris ^b   Schulze, Sandra ^b   Friese, Klaus ^b   Jeschke, Udo ^b   Makrigiannakis, Antonis ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

HELLP; IUGR; Lewis antigens; Preeclampsia; Trophoblast

Indexed keywords

ANGIOGENIC FACTOR; BLOOD GROUP ANTIGEN; SIALYL LEWIS A ANTIGEN; SIALYL LEWIS X ANTIGEN; SIALYL LEWIS Y ANTIGEN; UNCLASSIFIED DRUG;

AMNION CELL; ANTIGEN EXPRESSION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTROPHOBLAST; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; FETUS; HELLP SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; STAINING; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; UPREGULATION;

ADULT; AMNION; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; APGAR SCORE; BIRTH WEIGHT; ENDOTHELIAL CELLS; FEMALE; FETAL GROWTH RETARDATION; FLUORESCENT ANTIBODY TECHNIQUE; HELLP SYNDROME; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LEWIS BLOOD-GROUP SYSTEM; OLIGOSACCHARIDES; PARAFFIN EMBEDDING; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES; TROPHOBLASTS;

EID: 34250810221     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-007-0293-7     Document Type: Article

References (22)

1. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH (2002) Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene 21:3631-3643
2. Brosens IA, Robertson WB, Dixon HG (1972) The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1:177-191
3. Burrows TD, King A, Loke YW (1994) Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta 15:21-33
4. Chaddha V, Viero S, Huppertz B, Kingdom J (2004) Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 9:357-369
5. Hakomori S (1991) Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 3:646-653
6. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Backer AE, Koch AE (2000) Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 164:4868-4877
7. Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K (2005) Expression of sialyl Lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res 25:1615-1622
8. King A, Loke YW (1988) Differential expression of blood-group-related carbohydrate antigens by trophoblast subpopulations. Placenta 9:513-521
9. Mylonas I, Speer R, Makovitzky J, Richter DU, Briese V, Jeschke U, Friese K (2000) Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114:405-411
10. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K (2003) Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Acta Histochem 105:245-252
11. Ohyama C, Tsuboi S, Fukuda M (1999) Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. Embo J 18:1516-1525
12. Pijnenborg R, Bland JM, Robertson WB, Brosens I (1983) Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4:397-413
13. Prakobphol A, Genbacev O, Gormley M, Kapidzic M, Fisher SJ (2006) A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta. Dev Biol 298:107-117
14. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81:1143-1152
15. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B, Scheidt E (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409:127-147
16. Stahn R, Goletz S, Wilmanowski R, Wang X, Briese V, Friese K, Jeschke U (2005) Human chorionic gonadotropin (hCG) as inhibitior of E-selectin-mediated cell adhesion. Anticancer Res 25:1811-1816
17. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R (1993) Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53:354-361
18. Walker JJ (2000) Pre-eclampsia. Lancet 356:1260-1265
19. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH (1997a) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139-2151
20. Zhou Y, Damsky CH, Fisher SJ (1997b) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99:2152-2164
21. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405-1423
22. Zhou Y, Genbacev O, Fisher SJ (2003) The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann N Y Acad Sci 995:73-83